Composition
- Active ingredients
- RESERPINE 0.25MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RESERPINE 0.25MG · TabletANDA080446-001 · Discontinued
- RESERPINE 0.25MG · TabletANDA080582-001 · Discontinued
- RESERPINE 1MG · TabletANDA080582-002 · Discontinued
- RESERPINE 0.25MG · TabletANDA080975-002 · Discontinued
- RESERPINE 1MG · TabletANDA080975-003 · Discontinued
- RESERPINE 0.1MG · TabletANDA080975-001 · Discontinued
- RESERPINE 0.1MG · TabletANDA089020-001 · Discontinued
- RESERPINE 0.1MG · TabletNDA009627-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA009627-002 · Discontinued
- RESERPINE 0.1MG · TabletNDA009667-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA009667-002 · Discontinued
- RESERPINE 0.1MG · TabletNDA009859-001 · Discontinued
- RESERPINE 0.25MG · TabletNDA009859-002 · Discontinued
- RESERPINE 0.25MG · TabletANDA080637-001 · Discontinued
At a glance
- Brand name
- Reserpine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Watson Labs
- Status
- Discontinued
- FDA approval
- 22 Dec 1971
- Application
- ANDA080393-001